Pharma News

This section covers the managerial aspects in the Pharma industry.

West Pharmaceutical Announces Expanded Contract Manufacturing Capabilities in Ireland

Wednesday, November 30, 2016

West Pharmaceutical Services Inc a global leader in innovative solutions for injectable drug administration today announced the completion of a 60000 square foot expansion at its contract manufacturing facility near Mulhuddart County Dublin The expansion is in response to customer demand for medical..

German Merck, Pfizer get FDA priority review for cancer drug

Wednesday, November 30, 2016

German drugmaker Merck KGaA and US partner Pfizer have been granted priority review status in the United States as they seek approval to fight a rare and aggressive form of skin cancer with immunotherapy drug avelumab The US Food and Drug Administration has accepted the request for approval and wil..

Novo Nordisk reports Tresiba insulin achieves target in study

Wednesday, November 30, 2016

Novo Nordisk39s longacting insulin blockbuster Tresiba has a safe cardiovascular profile and reduces episodes of severely low blood glucose levels in patients with type 2 diabetes the Denmarkbased company said on Tuesday Type 2 diabetics who need insulin to control their blood sugar risk having too..

Idera Pharmaceuticals And Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement For The Worldwide Rights To IMO-9200

Wednesday, November 30, 2016

Idera Pharmaceuticals Inc and Vivelix Pharmaceuticals Ltd announced that they have entered into an exclusive license and collaboration agreement granting Vivelix worldwide rights to develop and market IMO9200 an antagonist of TLR 78 and 9 for nonmalignant gastrointestinal disorders As part of the ag..

Patheon To Acquire Active Pharmaceutical Ingredients (API) Manufacturing Facility From Roche Holdings, Inc.,

Tuesday, November 29, 2016

Patheon NV a leading global provider of highquality drug development and delivery solutions to the pharmaceutical and biopharma sectors announced that it has signed a definitive agreement to acquire a stateoftheart active pharmaceutical ingredients API manufacturing facility in Florence South Caroli..

Sun Pharma launches first branded drug BromSite in US

Tuesday, November 29, 2016

Indias largest drug maker Sun Pharma announced it will launch its first branded ophthalmic drug BromSite in the US through Sun Ophthalmics a dedicated division to market drugs related to eye related disorders Approved by the US FDA in April this year BromSite is a nonsteroidal antiinflammatory drug..

Monosol RX filed new drug application with U.S. FDA

Tuesday, November 29, 2016

Monosol RX filed new drug application with US Food and drug administration for tadalafil pharmfilm for treatment of erectile dysfunction Monosol RX Inc tadalafil pharmfilm will be offered in single pack doses and is expected to have several orange book listed patents upon approval Monosol RX cu..

Galapagos NV reports initiation of a phase 1 study with GLPG2737

Tuesday, November 29, 2016

Galapagos NV says reports initiation of a phase 1 study in healthy volunteers with GLPG2737 a novel C2 corrector drug for cystic fibrosis Galapagos NV says topline results from this phase 1 study with GLPG2737 are expected in Q2 of 2017 Galapagos NV says initiation of phase 1 study triggers a 10 m..

FPS Still Looks Ahead - FPS is pleased to announce the enlargement of his production plant

Monday, November 28, 2016

FPS Food and Pharma Systems a leader company in design manufacture and installation of Fine Size Reduction machines for micronizing and Containment Solutions for Sterile andor Highly Potent API discloses the beginning of the plants enlargement in FiorenzuoladArda The new fabricate will allow an imp..

PharmaMar begins a Phase I study of PM1183 in Japan for the treatment of solid tumors

Monday, November 28, 2016

PharmaMar has announced the start of an openlabel multicenter Phase I study in Japan to evaluate the recommended dose RD of PM1183 lurbinectedin in patients with certain types of unresectableadvanced solid tumors The main objective of the study is to determine the recommended dose of PM1183 in Japa..

Galenica says FDA approves supplemental new drug application for Veltassa

Monday, November 28, 2016

FDA approves supplemental new drug application SNDA for Veltassa removing boxed warning regarding drugdrug interactions Approval reinforces potential of Veltassa as a key platform of additional growth for Vifor Pharma Vifor Pharma to make necessary investments to achieve veltassa39s significant mid..

J&J makes takeover approach for Swiss drugmaker Actelion

Saturday, November 26, 2016

US healthcare company Johnson Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover Bloomberg reported on Thursday citing people it said were familiar with the matter The report said deliberations were still at an early stage following Johnson Johnson39s JJ initi..

Intellipharmaceutics submits new drug application for Rexista

Saturday, November 26, 2016

Intellipharmaceutics submits new drug application for Rexistaoxycodone hydrochloride extended release an abuse deterrent opioid analgesic for the treatment of moderate to severe pain Intellipharmaceutics International Has identified potential manufacturing partners currently evaluating manufacturi..

Moberg Pharma divests Pediacare For $5.0 Million

Friday, November 25, 2016

Moberg Pharma AB announces that the company has entered into an agreement with Strides Pharma Inc to divest the brand PediaCare for a total consideration of 5 million plus the inventory value at closing Moberg Pharmas strategy is to build value through profitable growth of strategic brands to incre..

GSK chases Astra with start of big anemia drug trials

Friday, November 25, 2016

GlaxoSmithKline has started pivotal trials of an experimental anemia drug chasing AstraZeneca in the race to develop a medicine that mimics the body39s response to high altitude GSK39s daprodustat given as a pill is designed to displace injectable EPO products that are used widely in patients with ..

Shanghai Fosun Pharmaceutical Group unit gets GMP certificate

Friday, November 25, 2016

Shanghai Fosun Pharmaceutical Group Co Ltd Says its unit received goods manufacture practice GMP certificate from Hunan Food and Drug Administration Bureau Says certificate issued to bulk drug lorazepam manufactured by the unit and the valid period is until Nov 6 2021 Source reuterscom ..

Neovacs signs production partnership with 3P Biopharmaceuticals

Thursday, November 24, 2016

Neovacs a leader in active immunotherapies for the treatment of autoimmune diseases announced a partnership with 3P Biopharmaceuticals a leader in the production of biological drugs for the manufacture of interferon alpha IFN Todays collaboration follows the recent acquisition of the technology for ..

Lilly's drug for Alzheimer's fails big trial; shares drop

Thursday, November 24, 2016

The failure of Eli Lilly and Co39s Alzheimer39s treatment to slow declines in mental capacity of patients with even mild symptoms cast serious doubt over whether a longheld approach to the memoryrobbing disease could provide meaningful benefit to millions of people at risk Many investors and famili..

WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership

Thursday, November 24, 2016

WuXi Biologics a WuXi AppTec group company and a leading openaccess RD capability and technology platform company dedicated to expediting global biologics development and Prima Biomed Ltd Prima an ASX PRR and Nasdaq PBMD listed company developing IMP321 a recombinant soluble LAG3 protein and other L..

Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease

Wednesday, November 23, 2016

Allergan plc a leading global pharmaceutical company today announced that it has completed the acquisition of Chase Pharmaceuticals Corporation a clinicalstage biopharmaceutical company focused on the development of improved treatments for neurodegenerative disorders including Alzheimer39s disease A..

TOP